South African patients benefit from three essential regulatory safeguards implemented by SAHPRA to ensure medicine and device safety. First, rigorous pre-market assessment evaluates all medicines, medical devices, and complementary medicines before they reach pharmacy shelves, ensuring that only products meeting strict safety and efficacy standards receive market authorization. Second, continuous post-market surveillance systems monitor real-world safety data, enabling healthcare authorities to detect previously unknown adverse effects as they occur in clinical practice.
Third, SAHPRA’s statutory enforcement powers provide rapid response mechanisms when safety concerns emerge. The authority can implement product recalls, restrict indications, or impose additional monitoring requirements to prevent patient harm. This three-layered approach—combining rigorous gatekeeping with real-time vigilance and enforcement authority—establishes a comprehensive patient protection system. Understanding these safeguards helps healthcare consumers recognize that regulatory oversight continues throughout a product’s entire commercial lifecycle, not merely at the approval stage.
Read the full article on GMJ Newsroom.
Was this article helpful?
